The estimated Net Worth of Andres Fajardo is at least $349 Tausend dollars as of 19 January 2024. Mr Fajardo owns over 1,561 units of Clever Leaves stock worth over $4 and over the last 4 years he sold CLVR stock worth over $45,831. In addition, he makes $303,078 as Pres & Director at Clever Leaves.
Mr has made over 7 trades of the Clever Leaves stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 1,561 units of CLVR stock worth $4,496 on 19 January 2024.
The largest trade he's ever made was selling 57,669 units of Clever Leaves stock on 17 January 2023 worth over $23,068. On average, Mr trades about 6,093 units every 63 days since 2021. As of 19 January 2024 he still owns at least 21,795 units of Clever Leaves stock.
You can see the complete history of Mr Fajardo stock trades at the bottom of the page.
Andres Fajardo is the Pres & Director at Clever Leaves.
As the Pres & Director of Clever Leaves, the total compensation of Mr Fajardo at Clever Leaves is $303,078. There are no executives at Clever Leaves getting paid more.
Mr Fajardo is 43, he's been the Pres & Director of Clever Leaves since . There are 2 older and 3 younger executives at Clever Leaves. The oldest executive at Clever Leaves Holdings Inc. is David M. Kastin Esq., 53, who is the Gen. Counsel & Corp. Sec..
Andres's mailing address filed with the SEC is C/O CLEVER LEAVES HOLDINGS INC., 6501 CONGRESS AVE, BOCA RATON, FL, 33487.
Over the last 4 years, insiders at Clever Leaves have traded over $235,856 worth of Clever Leaves stock. The most active insiders traders include Elisabeth H Demarse, Andres Fajardo und Kyle Detwiler. On average, Clever Leaves executives and independent directors trade stock every 29 days with the average trade being worth of $1. The most recent stock trade was executed by Henry R Iii Hague on 8 March 2024, trading 170 units of CLVR stock currently worth $563.
Clever Leaves Holdings Inc. operates as a cannabis company. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. The company was founded in 2017 and is based in Boca Raton, Florida.
Clever Leaves executives and other stock owners filed with the SEC include: